
S0495 The Safety Profile of Tegaserod 6 Mg BID in Irritable Bowel Syndrome With Constipation in Women <65 Years of Age Without Cardiovascular Disease History
Author(s) -
Eric D. Shah,
Brian E. Lacy,
William D. Chey,
Lin Chang,
Darren M. Brenner
Publication year - 2020
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/01.ajg.0000704028.06576.5a
Subject(s) - tegaserod , medicine , constipation , discontinuation , irritable bowel syndrome , nausea , abdominal pain , adverse effect , diarrhea , placebo , population , gastroenterology , environmental health , pathology , alternative medicine